Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia.
Saved in:
| Title: | Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia. |
|---|---|
| Authors: | Lin WY; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Fordham SE; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Sunter N; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Elstob C; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Rahman T; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Willmore E; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Shepherd C; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Strathdee G; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Mainou-Fowler T; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Piddock R; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Mearns H; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Barrow T; Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Marr H; Department of Haematology, Freeman Hospital, Newcastle upon Tyne, UK., Wallis J; Department of Haematology, Freeman Hospital, Newcastle upon Tyne, UK., Summerfield G; Queen Elizabeth Hospital, Gateshead, UK., Marshall S; City Hospitals Sunderland NHS Trust, Sunderland, UK., Pettitt A; University of Liverpool, Liverpool, UK., Pepper C; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Fegan C; Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK., Forconi F; Cancer Sciences Unit, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, University of Southampton, Southampton, UK., Dyer MJS; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Jayne S; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Sellors A; The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Schuh A; University of Oxford, Oxford, UK., Robbe P; University of Oxford, Oxford, UK., Oscier D; Royal Bournemouth Hospital, Bournemouth, UK., Bailey J; Hull University Teaching Hospital NHS Trust, Hull, UK., Rais S; Hull University Teaching Hospital NHS Trust, Hull, UK., Bentley A; Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK., Cawkwell L; University of Hull, Hull, UK., Evans P; Haematological Malignancy Diagnostic Service Laboratory, St James' Institute of Oncology, Leeds, UK., Hillmen P; Section of Experimental Haematology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Pratt G; University of Birmingham, Birmingham, UK., Allsup DJ; Hull University Teaching Hospital NHS Trust, Hull, UK. hycda1@hyms.ac.uk.; Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK. hycda1@hyms.ac.uk., Allan JM; Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. james.allan@newcastle.ac.uk. |
| Source: | Nature communications [Nat Commun] 2021 Jan 28; Vol. 12 (1), pp. 665. Date of Electronic Publication: 2021 Jan 28. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-020-20822-9 |
